Moderna taps AWS as preferred cloud partner amid COVID-19 vaccine race - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 51%

Italia Notizia Notizia

Italia Ultime Notizie,Italia Notizie

$29 billion biotech company Moderna just signed a big cloud deal with Amazon Web Services, even as the race for a COVID-19 vaccine accelerates

Biotech company Moderna on Wednesday announced that it has chosen Amazon Web Services as its preferred cloud partner.

The company is seen as a leader in COVID-19 vaccine research, entering its third phase of clinical trials late July.$29 billion biotech company Moderna announced a new partnership with Amazon Web Services on Wednesday that will see the cloud giant become its "preferred" cloud provider. The deal will also see Moderna tap AWS as its standard platform for doing analytics and machine learning.

"With AWS, our researchers have the ability to quickly design and execute research experiments and rapidly uncover new insights to get potentially life-saving treatments into production faster," Moderna CEO Stéphane Bancel said in that press release. Biotech giants like Moderna are increasingly modernizing their IT infrastructures in the hunt for new drugs and treatments,

Abbiamo riassunto questa notizia in modo che tu possa leggerla velocemente. Se sei interessato alla notizia puoi leggere il testo completo qui. Leggi di più:

 /  🏆 729. in İT
 

Grazie per il tuo commento. Il tuo commento verrà pubblicato dopo essere stato esaminato.

Italia Ultime Notizie, Italia Notizie

Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.

Inside story: Humana's $100 million bet on telehealth startup Heal - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Fonte: BusinessInsider - 🏆 729. / 51 Leggi di più »